Caverzan, M.D.; Morales Vasconsuelo, A.B.; Cerchia, L.; Palacios, R.E.; Chesta, C.A.; Ibarra, L.E.
Preclinical Toxicological Characterization of Porphyrin-Doped Conjugated Polymer Nanoparticles for Photodynamic Therapy. Pharmaceutics 2025, 17, 593.
https://doi.org/10.3390/pharmaceutics17050593
AMA Style
Caverzan MD, Morales Vasconsuelo AB, Cerchia L, Palacios RE, Chesta CA, Ibarra LE.
Preclinical Toxicological Characterization of Porphyrin-Doped Conjugated Polymer Nanoparticles for Photodynamic Therapy. Pharmaceutics. 2025; 17(5):593.
https://doi.org/10.3390/pharmaceutics17050593
Chicago/Turabian Style
Caverzan, MatÃas Daniel, Ana Belén Morales Vasconsuelo, Laura Cerchia, Rodrigo Emiliano Palacios, Carlos Alberto Chesta, and Luis Exequiel Ibarra.
2025. "Preclinical Toxicological Characterization of Porphyrin-Doped Conjugated Polymer Nanoparticles for Photodynamic Therapy" Pharmaceutics 17, no. 5: 593.
https://doi.org/10.3390/pharmaceutics17050593
APA Style
Caverzan, M. D., Morales Vasconsuelo, A. B., Cerchia, L., Palacios, R. E., Chesta, C. A., & Ibarra, L. E.
(2025). Preclinical Toxicological Characterization of Porphyrin-Doped Conjugated Polymer Nanoparticles for Photodynamic Therapy. Pharmaceutics, 17(5), 593.
https://doi.org/10.3390/pharmaceutics17050593
